{"id": "chatcmpl-B2EcyN8VQmMiY4xyUZxqz6FZZBeMu", "object": "chat.completion", "created": 1739872584, "model": "gpt-4o-mini-2024-07-18", "choices": [{"index": 0, "message": {"role": "assistant", "content": null, "function_call": {"name": "get_weaksignals", "arguments": "{\"signals\":[{\"name\":\"Psychedelics as Medicine\",\"description\":\"Australia recognizes MDMA and psilocybin as medicinal substances for mental health.\",\"change\":\"Shift from illegal status of psychedelics to approved medical treatments.\",\"10-year\":\"Psychedelics become a mainstream aspect of mental health treatment in Australia and beyond.\",\"driving-force\":\"Growing evidence of efficacy for treating mental health conditions with psychedelics.\",\"relevancy\":5},{\"name\":\"Research and Regulatory Framework\",\"description\":\"Psychiatrists must adhere to a new ethical research process for prescribing psychedelics.\",\"change\":\"Transition from a loosely regulated to a more structured and scrutinized research environment.\",\"10-year\":\"A comprehensive regulatory framework for psychedelic therapy enhances patient safety and research quality.\",\"driving-force\":\"Increased focus on ethical standards and patient safety in psychiatric practices.\",\"relevancy\":4},{\"name\":\"Potential for Wider Application\",\"description\":\"Calls for psilocybin's reclassification to include more psychiatric disorders.\",\"change\":\"Expanding therapeutic applications from depression to various psychiatric disorders.\",\"10-year\":\"Psychedelic treatments are widely used for multiple psychiatric conditions beyond their initial approval.\",\"driving-force\":\"An increasing recognition of the limitations of current mental health treatments and the need for alternatives.\",\"relevancy\":4},{\"name\":\"Clinical Trials and Research Development\",\"description\":\"Ongoing trials are investigating various psychiatric uses for psilocybin.\",\"change\":\"From limited therapeutic use to extensive clinical trials exploring multiple applications.\",\"10-year\":\"A robust pipeline of psychedelic-assisted therapies for various mental health conditions becomes available.\",\"driving-force\":\"The need for innovative treatments drives investment and interest in psychedelic research.\",\"relevancy\":4},{\"name\":\"Therapist Training and Standards\",\"description\":\"Advocacy for high-quality therapist training for psychedelic-assisted therapies.\",\"change\":\"Shift from untrained supervision to rigorous training protocols for therapists.\",\"10-year\":\"The establishment of standardized training programs for therapists using psychedelics in practice.\",\"driving-force\":\"Ensuring patient safety and effective therapeutic outcomes through qualified practitioners.\",\"relevancy\":4}]}"}, "refusal": null}, "logprobs": null, "finish_reason": "function_call"}], "usage": {"prompt_tokens": 1075, "completion_tokens": 430, "total_tokens": 1505, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_13eed4fce1"}